Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumicitabine in hospitalized adults with RSV
NCT02673476Phase 2Completed
- Sponsor
- Alios BioPharma
- Start
- Feb 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of lumicitabine in respiratory syncytial virus infection (RSV), sponsored by Alios BioPharma. Started Feb 2016; status: completed.
02
Drugs
lumicitabine
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02673476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673476.